NET-02: a multi-center, randomised, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC)
| dc.contributor.author | McNamara, Mairead G | |
| dc.contributor.author | Swain, J | |
| dc.contributor.author | Craig, Z | |
| dc.contributor.author | Wadsley, J | |
| dc.contributor.author | Reed, N | |
| dc.contributor.author | Faluyi, OO | |
| dc.contributor.author | Lamarca, Angela | |
| dc.contributor.author | Hubner, Richard A | |
| dc.contributor.author | Mansoor, Was | |
| dc.contributor.author | Sarker, D | |
| dc.contributor.author | Howard, HC | |
| dc.contributor.author | Cairns, DA | |
| dc.contributor.author | Meyer, T | |
| dc.contributor.author | Valle, Juan W | |
| dc.date.accessioned | 2019-11-19T16:01:06Z | |
| dc.date.available | 2019-11-19T16:01:06Z | |
| dc.date.issued | 2019 | en |
| dc.identifier.citation | McNamara MG, Swain J, Craig Z, Wadsley J, Reed N, Faluyi OO, et al. NET-02: a multi-center, randomised, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC). J Clin Oncol. 2019;37(15_suppl):TPS4158-TPS. | en |
| dc.identifier.doi | 10.1200/JCO.2019.37.15_suppl.TPS4158 | en |
| dc.identifier.uri | http://hdl.handle.net/10541/622456 | |
| dc.language.iso | en | en |
| dc.relation.url | https://dx.doi.org/10.1200/JCO.2019.37.15_suppl.TPS4158 | en |
| dc.title | NET-02: a multi-center, randomised, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC) | en |
| dc.type | Meetings and Proceedings | en |
| dc.contributor.department | Institute of Cancer Sciences, University of Manchester, Medical Oncology Department, The Christie NHS Foundation Trust, Manchester | en |
| dc.identifier.journal | Journal of Clinical Oncology | en |